Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
about
Lack of Sprouty 1 and 2 enhances survival of effector CD8 T cells and yields more protective memory cellsThe Potential of CAR T Cell Therapy in Pancreatic CancerCAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor ChallengeCytokine release syndrome: grading, modeling, and new therapySurface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
P2860
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Determinants of response and r ...... chronic lymphocytic leukemia.
@en
Determinants of response and resistance to CD19 chimeric antigen receptor
@nl
type
label
Determinants of response and r ...... chronic lymphocytic leukemia.
@en
Determinants of response and resistance to CD19 chimeric antigen receptor
@nl
prefLabel
Determinants of response and r ...... chronic lymphocytic leukemia.
@en
Determinants of response and resistance to CD19 chimeric antigen receptor
@nl
P2093
P2860
P50
P1433
P1476
Determinants of response and r ...... chronic lymphocytic leukemia.
@en
P2093
Alexander C Huang
Alina C Boesteanu
Changfeng Zhang
Corin Dorfmeier
David E Ambrose
David L Porter
Donald L Siegel
E John Wherry
Edward Pequignot
Elena J Orlando
P2860
P2888
P304
P356
10.1038/S41591-018-0010-1
P407
P577
2018-04-30T00:00:00Z
P6179
1103686011